Odysseas D. Kostas

Director, Savara Inc.

Companies

Amarin CorporationBoard member Mar 10, 2023 to now¹
Armata Pharmaceuticals, Inc.Board member Feb 14, 2020 to now²
Innoviva, Inc.Board member Dec 21, 2017 to Jun 20, 2024³
Sarissa Capital Acquisition Corp.Senior Managing Director Oct 20, 2020 to Oct 20, 2020⁴
Enzon PharmaceuticalsBoard member Oct 7, 2013 to Oct 7, 2013⁵
Savara IncBoard member Feb 3, 2010 to Jul 1, 2010⁶

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Innoviva, Inc. INVA122,625 shares⁷$2.6M at $21.07Jun 17, 2024
Amarin Corporation AMRN836 shares⁸$9.6K at $11.52Apr 18, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

Apr 18, 2026Shares withheld for tax 403 shares at $14.98 of Amarin Corporation⁸
Apr 18, 2026Exercised options 838 shares of Amarin Corporation⁸
Apr 18, 2025Shares withheld for tax 437 shares at $9.11 of Amarin Corporation⁹
Apr 18, 2025Exercised options 838 shares of Amarin Corporation⁹
Jun 17, 2024Granted 13,923 shares of Innoviva, Inc.⁷
May 22, 2023Granted 16,495 shares of Innoviva, Inc.¹⁰
Apr 25, 2022Granted 12,647 shares of Innoviva, Inc.¹¹

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARAmarin Corporation, Board member
2
SEC EDGARArmata Pharmaceuticals, Inc., Board member
3
SEC EDGARInnoviva, Inc., Board member
4
SEC EDGARSarissa Capital Acquisition Corp., Senior Managing Director
5
SEC EDGAREnzon Pharmaceuticals, Board member
6
SEC EDGARSavara Inc, Board member
7
SEC EDGARInnoviva, Inc. shares after the filing of Jun 17, 2024
8
SEC EDGARAmarin Corporation shares after the filing of Apr 18, 2026
9
SEC EDGARForm 4 filed Apr 22, 2025
10
SEC EDGARForm 4 filed May 24, 2023
11
SEC EDGARForm 4 filed Apr 27, 2022